Clearwater Capital Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Clearwater Capital Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.91M	Sell	45,297 -26,991	-37%	-$860K	0.14%	54
2026 Q1	$1.91M	Sell	72,288 -589	-0.8%	-$17.2K	0.15%	51
2025 Q4	$2.11M	Sell	72,877 -3,930	-5%	-$118K	0.18%	52
2025 Q3	$2.13M	Sell	76,807 -186,910	-71%	-$4.72M	0.18%	53
2025 Q2	$6.42M	Buy	263,717 +67,842	+35%	+$1.49M	0.59%	35
2025 Q1	$4.07M	Buy	195,875 +37,970	+24%	+$954K	0.39%	41
2024 Q4	$3.72M	Sell	157,905 -26,019	-14%	-$640K	0.36%	41
2024 Q3	$4.71M	Buy	183,924 +11,263	+7%	+$287K	0.46%	39
2024 Q2	$4.05M	Sell	172,661 -1,098	-0.6%	-$27.7K	0.43%	38
2024 Q1	$5M	Buy	173,759 +6,385	+4%	+$192K	0.53%	38
2023 Q4	$5.49M	Sell	167,374 -75,662	-31%	-$2.06M	0.62%	33
2023 Q3	$6.77M	Buy	243,036 +280	+0.1%	+$9.15K	0.83%	28
2023 Q2	$8.28M	Sell	242,756 -39	-0%	-$1.23K	0.99%	27
2023 Q1	$7.3M	Sell	242,795 -3,117	-1%	-$96.6K	0.89%	28
2022 Q4	$6.94M	Buy	245,912 +41,053	+20%	+$1.3M	0.9%	31
2022 Q3	$6.73M	Buy	204,859 +37,245	+22%	+$1.37M	0.93%	33
2022 Q2	$5.28M	Sell	167,614 -37,012	-18%	-$1.29M	0.72%	36
2022 Q1	$9.4M	Buy	204,626 +57,985	+40%	+$2.76M	1.08%	27
2021 Q4	$8.98M	Sell	146,641 -651	-0.4%	-$45K	0.99%	31
2021 Q3	$11M	Buy	147,292 +8,403	+6%	+$705K	1.28%	24
2021 Q2	$12.8M	Buy	138,889 +6,121	+5%	+$520K	1.49%	20
2021 Q1	$11.8M	Buy	132,768 +13,066	+11%	+$1.3M	1.47%	18
2020 Q4	$11.2M	Buy	119,702 +15,464	+15%	+$1.23M	1.48%	21
2020 Q3	$6.64M	Buy	104,238 +9,277	+10%	+$544K	1.04%	24
2020 Q2	$4.95M	Buy	+94,961	New	+$4.07M	0.83%	29

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Clearwater Capital Advisors's ARKG Position: Q2 2026 in Review

Clearwater Capital Advisors reduced its ARK Genomic Revolution ETF (ARKG) stake by 37% in Q2 2026, selling an estimated $860K and leaving 45,297 shares worth $1.91M. The position accounts for 0.14% of the portfolio, ranked #54.

Clearwater Capital Advisors first reported a position in ARKG in Q2 2020 and has held it in 25 quarters since. The position peaked at $12.8M in Q2 2021. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Clearwater Capital Advisors held 45,297 shares of ARK Genomic Revolution ETF worth $1.91M as of Q2 2026.
Clearwater Capital Advisors sold 26,991 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $860K.
ARK Genomic Revolution ETF made up 0.14% of Clearwater Capital Advisors's portfolio in Q2 2026, its #54 holding.
Clearwater Capital Advisors first reported a position in ARK Genomic Revolution ETF in Q2 2020 and has held it in 25 quarters since.
Clearwater Capital Advisors's ARK Genomic Revolution ETF position peaked at $12.8M in Q2 2021.
272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Clearwater Capital Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.